Thomas Haas

2.1k total citations
30 papers, 1.1k citations indexed

About

Thomas Haas is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Thomas Haas has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Thomas Haas's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Eosinophilic Esophagitis (3 papers). Thomas Haas is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Eosinophilic Esophagitis (3 papers). Thomas Haas collaborates with scholars based in United States, Austria and Germany. Thomas Haas's co-authors include Stanley K. Henshaw, Susheela Singh, David Tacha, Ryan Bremer, Christian Datz, Ronald Hapke, Frank LoVecchio, David Y. Graham, Adam Elfant and Steven F. Moss and has published in prestigious journals such as Gastroenterology, Clinical Chemistry and Gastrointestinal Endoscopy.

In The Last Decade

Thomas Haas

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Haas United States 14 334 238 199 160 138 30 1.1k
Vicky Thursfield Australia 21 300 0.9× 319 1.3× 617 3.1× 134 0.8× 37 0.3× 48 1.3k
Chris Holcombe United Kingdom 20 829 2.5× 325 1.4× 526 2.6× 99 0.6× 186 1.3× 81 1.8k
Jennifer Wright United States 21 276 0.8× 573 2.4× 521 2.6× 237 1.5× 263 1.9× 61 1.9k
Sang Kyun Sohn South Korea 20 110 0.3× 218 0.9× 360 1.8× 168 1.1× 29 0.2× 61 1.2k
Wendy Kohlmann United States 28 407 1.2× 291 1.2× 982 4.9× 271 1.7× 44 0.3× 111 3.0k
Katharina Emrich Germany 21 277 0.8× 293 1.2× 751 3.8× 97 0.6× 15 0.1× 50 1.3k
Hyun‐Jeong Shim South Korea 19 268 0.8× 227 1.0× 329 1.7× 105 0.7× 31 0.2× 50 824
Stefan Schanz Germany 19 186 0.6× 68 0.3× 136 0.7× 32 0.2× 54 0.4× 40 932
Isabella Corazziari Italy 12 156 0.5× 282 1.2× 512 2.6× 160 1.0× 13 0.1× 16 1.0k
David M. Gershenson United States 18 251 0.8× 133 0.6× 695 3.5× 130 0.8× 31 0.2× 28 1.6k

Countries citing papers authored by Thomas Haas

Since Specialization
Citations

This map shows the geographic impact of Thomas Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Haas more than expected).

Fields of papers citing papers by Thomas Haas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Haas. The network helps show where Thomas Haas may publish in the future.

Co-authorship network of co-authors of Thomas Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Haas. A scholar is included among the top collaborators of Thomas Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Haas. Thomas Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldsmith, Jeffrey D., Megan L. Troxell, Sinchita Roy‐Chowdhuri, et al.. (2024). Principles of Analytic Validation of Immunohistochemical Assays: Guideline Update. Archives of Pathology & Laboratory Medicine. 148(6). e111–e153. 20 indexed citations
2.
Reider, Simon, Gottfried Novacek, Thomas Haas, et al.. (2023). Positionspapier der Arbeitsgruppe Chronisch Entzündliche Darmerkrankungen der ÖGGH zum Einsatz von Vedolizumab subkutan. Zeitschrift für Gastroenterologie. 61(11). 1518–1525. 1 indexed citations
3.
Novacek, Gottfried, Walter Reinisch, Christoph Högenauer, et al.. (2022). Tofacitinib in the treatment of ulcerative colitis. Wiener klinische Wochenschrift. 135(1-2). 1–13. 3 indexed citations
4.
Blesl, Andreas, Christoph Högenauer, Robert Koch, et al.. (2019). Stellenwert von Vedolizumab als Erstlinienbiologikum bei chronisch-entzündlichen Darmerkrankungen (CED). 17(1). 10–17. 1 indexed citations
5.
El‐Serag, Hashem B., John Y. Kao, Fasiha Kanwal, et al.. (2018). Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clinical Gastroenterology and Hepatology. 16(7). 992–1002.e6. 183 indexed citations
6.
Müller, Thomas, et al.. (2017). Benefit on motor and non-motor behavior in a specialized unit for Parkinson’s disease. Journal of Neural Transmission. 124(6). 715–720. 33 indexed citations
7.
Tacha, David, et al.. (2015). Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma. Applied immunohistochemistry & molecular morphology. 23(10). 711–716. 37 indexed citations
8.
Tang, Ping, David G. Hicks, Qi Yang, et al.. (2014). A New Rabbit Monoclonal E-Cadherin Antibody [EP700Y] Shows Higher Sensitivity Than Mouse Monoclonal E-Cadherin [HECD-1] Antibody in Breast Ductal Carcinomas and Does Not Stain Breast Lobular Carcinomas. Applied immunohistochemistry & molecular morphology. 22(8). 606–612. 4 indexed citations
9.
Müller, Thomas, Stefan Barghorn, Thomas Haas, et al.. (2014). Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients. Journal of Neural Transmission. 122(6). 841–848. 13 indexed citations
10.
11.
Fitzgibbons, Patrick L., Linda Bradley, Lisa A. Fatheree, et al.. (2014). Principles of Analytic Validation of Immunohistochemical Assays: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Archives of Pathology & Laboratory Medicine. 138(11). 1432–1443. 180 indexed citations
12.
Tacha, David, et al.. (2012). A 6-Antibody Panel for the Classification of Lung Adenocarcinoma Versus Squamous Cell Carcinoma. Applied immunohistochemistry & molecular morphology. 20(3). 201–207. 30 indexed citations
13.
Lott, Robert L., Freida L. Carson, Rhona J. Souers, et al.. (2011). The College of American Pathologists and National Society for Histotechnology workload study.. PubMed. 135(6). 728–36. 13 indexed citations
14.
Gasché, Christoph, Rayko Evstatiev, Thomas Haas, et al.. (2011). Diagnose und Behandlung von Eisenmangel und Anämie bei chronisch entzündlichen Darmerkrankungen. Konsensus der österreichischen Arbeitsgruppe für CED. Zeitschrift für Gastroenterologie. 49(5). 627–632. 15 indexed citations
15.
Dulic-Lakovic, E, Dietmar Hübner, H Fuchssteiner, et al.. (2011). Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment. Gastrointestinal Endoscopy. 74(3). 573–580. 61 indexed citations
16.
Reinisch, Walter, Clemens Dejaco, T Feichtenschlager, et al.. (2011). Infliximab in der Therapie des Morbus Crohn - ein praktischer Leitfaden: aktualisierter ÖGGH-Konsensus der Arbeitsgruppe Chronisch-entzündliche Darmerkrankungen der ÖGGH. Zeitschrift für Gastroenterologie. 49(4). 534–542. 1 indexed citations
17.
Tacha, David, et al.. (2011). TTF-1, Napsin A, p63, TRIM29, Desmoglein-3 and CK5: An Evaluation of Sensitivity and Specificity and Correlation of Tumor Grade for Lung Adenocarcinoma versus Squamous Cell Carcinoma.. 1 indexed citations
18.
Reinisch, Walter, Thomas Haas, Arthur Kaser, et al.. (2009). Adalimumab in der Behandlung des Morbus Crohn – ein Konsensus der Arbeitsgruppe Chronisch Entzündliche Darmerkrankungen der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie. Zeitschrift für Gastroenterologie. 47(4). 372–380. 1 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vicky Thursfield Breakdown of academic impact, for papers by Chris Holcombe Breakdown of academic impact, for papers by Jennifer Wright Breakdown of academic impact, for papers by Sang Kyun Sohn Breakdown of academic impact, for papers by Wendy Kohlmann Breakdown of academic impact, for papers by Katharina Emrich Breakdown of academic impact, for papers by Hyun‐Jeong Shim Breakdown of academic impact, for papers by Stefan Schanz Breakdown of academic impact, for papers by Isabella Corazziari Breakdown of academic impact, for papers by David M. Gershenson
Rankless by CCL
2026